Pharmacokinetics and pharmacodynamics of mycophenolic acid in Nagase analbuminemic rats: Evaluation of protein binding effects using the modeling and simulation approach-Reference-Cited by-同舟云学术

Pharmacokinetics and pharmacodynamics of mycophenolic acid in Nagase analbuminemic rats: Evaluation of protein binding effects using the modeling and simulation approach

Published:2015-12 Issue:6 Volume:30 Page:441-448
ISSN:1347-4367
Container-title:Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Drug Metabolism and Pharmacokinetics

Author:

Yoshimura Kazuaki,Yano Ikuko,Kawanishi Misaki,Nakagawa Shunsaku,Yonezawa Atsushi,Matsubara Kazuo

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology

Reference28 articles.

1. Mycophenolate mofetil and its mechanisms of action;Allison;Immunopharmacology,2000

2. Immunosuppression: practice and trends;Kaufman;Am J Transpl,2004

3. Mycophenolate mofetil: fully utilizing its benefits for GvHD prophylaxis;Minagawa;Int J Hematol,2012

4. Maximum A posteriori Bayesian estimation of mycophenolic acid pharmacokinetics in renal transplant recipients at different postgrafting periods;Premaud;Ther Drug Monit,2005

5. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients;Staatz;Clin Pharmacokinet,2007

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum albumin level is associated with mycophenolic acid concentration in children with idiopathic nephrotic syndrome;European Journal of Pediatrics;2021-11-15

2. Pharmacokinetic Model Analysis of Supralingual, Oral and Intravenous Deliveries of Mycophenolic Acid;Pharmaceutics;2021-04-17

3. Validated LC–MS/MS method for quantitation of total and free mycophenolic acid concentration and its application to a pharmacokinetic study in pediatric renal transplant recipients;Biomedical Chromatography;2020-10-18

4. Application of genetically modified rodent models in drug discovery and development for translation of clinical ADME properties;Identification and Quantification of Drugs, Metabolites, Drug Metabolizing Enzymes, and Transporters;2020

5. Clinical Pharmacometrics for Rational Drug Treatment;YAKUGAKU ZASSHI;2019-10-01